Matches in Wikidata for { <http://www.wikidata.org/entity/Q59400440> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q59400440 description "im Jahr 2014 veröffentlichter wissenschaftlicher Artikel" @default.
- Q59400440 description "wetenschappelijk artikel" @default.
- Q59400440 description "наукова стаття, опублікована у 2014" @default.
- Q59400440 name "Agonistic 4-1bb antibodies in combination with inhibitory antibodies against CTLA-4, PD-L1 or LAG-3 ACT on CD8+ T cells in the tumor microenvironment and synergize to promote regression of established tumors" @default.
- Q59400440 name "Agonistic 4-1bb antibodies in combination with inhibitory antibodies against CTLA-4, PD-L1 or LAG-3 ACT on CD8+ T cells in the tumor microenvironment and synergize to promote regression of established tumors" @default.
- Q59400440 type Item @default.
- Q59400440 label "Agonistic 4-1bb antibodies in combination with inhibitory antibodies against CTLA-4, PD-L1 or LAG-3 ACT on CD8+ T cells in the tumor microenvironment and synergize to promote regression of established tumors" @default.
- Q59400440 label "Agonistic 4-1bb antibodies in combination with inhibitory antibodies against CTLA-4, PD-L1 or LAG-3 ACT on CD8+ T cells in the tumor microenvironment and synergize to promote regression of established tumors" @default.
- Q59400440 prefLabel "Agonistic 4-1bb antibodies in combination with inhibitory antibodies against CTLA-4, PD-L1 or LAG-3 ACT on CD8+ T cells in the tumor microenvironment and synergize to promote regression of established tumors" @default.
- Q59400440 prefLabel "Agonistic 4-1bb antibodies in combination with inhibitory antibodies against CTLA-4, PD-L1 or LAG-3 ACT on CD8+ T cells in the tumor microenvironment and synergize to promote regression of established tumors" @default.
- Q59400440 P1433 Q59400440-B16D4BC6-738A-4FD9-9F58-252B4592ECFF @default.
- Q59400440 P1476 Q59400440-AFBB8EDF-118B-4735-8094-A5AC4F1A3B2A @default.
- Q59400440 P2093 Q59400440-08638382-C276-4B39-B4B1-4659B881A95A @default.
- Q59400440 P2093 Q59400440-954DE1E8-5A33-4031-86D5-A3E13EB6916B @default.
- Q59400440 P2888 Q59400440-5C2C1284-53F9-4FCF-A273-4743C5820221 @default.
- Q59400440 P304 Q59400440-4208E37B-19FE-43AB-B5BF-14E3F6130A13 @default.
- Q59400440 P31 Q59400440-806F9FA1-C03A-49CD-BB4D-A31709EC91A5 @default.
- Q59400440 P356 Q59400440-2ACE9090-6D70-4D3C-9E0A-85AFA95719BD @default.
- Q59400440 P433 Q59400440-5FD6D2AB-EF87-41B4-9F2A-7E1FEB5BDA37 @default.
- Q59400440 P478 Q59400440-C7D4385D-5FA7-437B-99E9-F9D31F15EDF1 @default.
- Q59400440 P50 Q59400440-336F7367-1960-494B-93DD-F2B785E873D4 @default.
- Q59400440 P50 Q59400440-856FB02B-5353-4936-9AC8-BA72F788301D @default.
- Q59400440 P577 Q59400440-BD5F8033-059D-4518-A858-7987493FFA63 @default.
- Q59400440 P6179 Q59400440-A1BD22DB-A72D-49E3-A750-A58FC5579B4C @default.
- Q59400440 P921 Q59400440-E65B3B5B-0053-445B-A55E-4F64BB5C76E0 @default.
- Q59400440 P932 Q59400440-1C4749DF-B256-4120-900F-015C301593C0 @default.
- Q59400440 P356 2051-1426-2-S3-P213 @default.
- Q59400440 P1433 Q27725163 @default.
- Q59400440 P1476 "Agonistic 4-1bb antibodies in combination with inhibitory antibodies against CTLA-4, PD-L1 or LAG-3 ACT on CD8+ T cells in the tumor microenvironment and synergize to promote regression of established tumors" @default.
- Q59400440 P2093 "Brendan Horton" @default.
- Q59400440 P2093 "Stefani Spranger" @default.
- Q59400440 P2888 2051-1426-2-s3-p213 @default.
- Q59400440 P304 "P213" @default.
- Q59400440 P31 Q13442814 @default.
- Q59400440 P356 "10.1186/2051-1426-2-S3-P213" @default.
- Q59400440 P433 "Suppl 3" @default.
- Q59400440 P478 "2" @default.
- Q59400440 P50 Q27955522 @default.
- Q59400440 P50 Q88137719 @default.
- Q59400440 P577 "2014-01-01T00:00:00Z" @default.
- Q59400440 P6179 "1006296449" @default.
- Q59400440 P921 Q79460 @default.
- Q59400440 P932 "4292434" @default.